Swiss researchers may have discovered the reason drug-eluting stents cause thrombosis, and their study results are ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
UnitedHealthcare has announced its support for the “Door to Balloon (D2B): An Alliance for Quality” campaign ...
In a new, five-year agreement signed last week, Datascope’s InterVascular Division will become the distributor of Sorin ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Diagnostic & Invasive Cardiology editor Kim Phelan spoke with Jeff Mirviss, vice president of Stent Marketing at Boston ...
A new study, released today by the Society for Cardiovascular Angiography and Interventions, shows that the ...
The FDA panel that convened for an intense, two-day review of drug-eluting stents last week heard key testimony from ...
The FDA panel that is re-evaluating the safety of drug-eluting stents convenes Dec. 7 and 8 at the Hilton Washington DC ...
The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...
Recent downplay of the media’s attention to DES-related thrombosis during both the TCT and AHA conferences this fall may ...
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
Cordis Corp. has received approval from the FDA to market its PRECISE Nitinol Stent and ANGIOGUARD Emboli Capture guide ...
The tiny tools of interventional cardiology known as drug-eluting stents (which happen to comprise a gargantuan U.S ...
The first third-generation drug-eluting stent is now available to physicians and patients in many markets around the ...
A Netherlands study comparing two-year outcomes of a series of 708 consecutive diabetic patients (25 percent insulin ...